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The reaction of ozone (0,) with human blood plasma was studied to help understand possibleevcnts hat could occur in the respiratory trtit. Uric 
acid (quantitatively the most important scavenger) and ascorbic acid were oxidized quickly, protcin.SH groups were lost more slowly, and there 
was no loss or bilirubin or a-tocopherol. There was little formation of lipid hydroperoxides and no detectable formation of Chydroxynoncnal, 
hexanal or nonanal, or changes in lipoprotein clcrtrophoretic mobility. Uric acid in human upper airway secretions may play a significant role 
in removing inhaled 0,. Oxidative damage to lipids must not bc assumed to be the key mechanism of mrpiratory tract 0, toxicity. 
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1. INTRODUCTION 
Ozone (0,) is an important oxic component of pho- 
tochemical air pollution. It is believed that the powerful 
oxidizing ability of Oj is responsible for its adverse 
biological effects [l-4]. Oj can oxidize several biological 
molecules directly 11.41 and, in addition, it reacts lowly 
with water at physiological pH to yield highly reactive 
hydroxyl radicals [S]. Thus several biological antiox- 
idants, especially a-tocopherol, have been hypothesized 
to exert protection against damage by Oa in vivo [1,2] 
and it is widely believed that oxidative damage to lipids 
by Oj is a major mechanism of its toxicity [ 1,2,6]. 
The first biological fluids that come into contact with 
inhaled O3 are the respiratory tract lining fluids 
(RTLFs), which presumably serve to absorb and de- 
toxify some of the inhaled O3 so as to lower the amount 
that enters the more-vulnerable peripheral gas exchange 
regions of the lung [7,8]. Some information is available 
about the antioxidants of these fluids [S-13] but the 
problems of sampling them (by the techniques of respi- 
ratory tract lavage) have hindered elucidation of their 
precise comparative antioxidant capabilities, since 
lavage itself produces considerable and variable dilution 
of RTLFs and some of their constituents may be 
oxidized during the procedures [14,15]. 
By contrast, the antioxidant defences of human 
plasma have been well characterized (reviewed in [16]). 
When plasma is exposed to chemically produced per- 
oxyl radicals, to cigarette smoke or to oxidants gen- 
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erated by activated neutrophils, ascorbic acid appears 
to be a ‘first line of defence’ and its disappearance is
accompanied by the onset of peroxidation of plasma 
lipids [17-191. By contrast, although uric acid (a 
suggested physiological antioxidant 1201) has been dem- 
onstrated to have antioxidant properties in vitro [3,20- 
22], it has not been found to date to play a major protec- 
tive role in plasma exposed to oxidants [16]. We show 
here that uric acid is probably the most important sca- 
venger of O1 in human blood plasma, and we relate this 
observation to the presence of uric acid in upper RTLFs 
[8,23]. 
2. MATERIALS AND METHODS 
2.1. Piaswa 0, exposure 
Blood was drawn from healthy adult male volunteers (age range 
30-60) intn heparinized tubes and centrifuged to obtain plasma. 5 ml 
aliquots were placed in Falcon dishes in a closed container at 37OC 
and exposed to a humidified constantly monitored level of I6 ppm 0, 
in 5% COJ95% air as described in [24]. Control plasma was exposed 
to an identical gas-stream but without OS. Measurement of the con- 
centrations of plasma clcctrolytes (using a Beckman Synchron CX4 
autoanalymr) showed that, as expected [24], even I2 h or exposure 
caused no evaporation of water from the plasma, nor did the plasma 
pi-l change. 
2.2. Aulriowidants 
Antioxidants and uric acid oxidation products were mcasurcd by 
specific HPLC-based methods, and protein thiols using Ellman’s 
reagent [l7-19,251. 
Samples were analyzed for rrurts4hydroxy_2-noncnal (HNE) by 
forming the pcntafiuoroiwnzyi oGn~e trimethylsilyl cthcr d&.&vc 
and using GC/clectron capture ionization mass spectrometry and 
selected ion monitoring, by modihc&ons of :he methods d~~rilml in 
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126.27], Qunntitative analysis was performed by using a dcukrated 
HNE internal standard. HNE was synthesized as in [28] and its deu- 
tcrated analogue as in [27]. Both were stored as solutions in dichloro- 
methane at -80°C. Standard aqueous olutions of aldchydcs were 
prcparcd by evaporating the solvent under reduced pressure and dis- 
solving a weighed amount of the residue in a known volume of 




0 AsorbIc Acid 
8 so 0 Uric Acid 
8 
u 
the absorbance of the aqueous olution at 223 nm. o-(2,3,4,5,6-Rnta- 
fluorobcnzyl)-hydroxylamine hydrochloride (PFB.HCl) and N- 
.b 60 
mcthyl-N-(trimetl~yIsilyl)-triRuoroacetamide(MSTFA) were obtained g vtl 
from Aldrich Chemical Co. (Milwaukee. WI). Hexane(Optima grade) 
was from Fisher Chemical Co. (Fair Lawn, NJ). 
Samples were extrdcled by a modification of the method in [27]- To 
a conical 15 ml centrifuge tube was added 250~1 of butylated hydrox- 
t 20 
ytolucne solution (10 mg/ml in ethanol), 200 ~1 of2 mM EDTA, pH H 
7.0, a volume of aqueous olution containing IO ng of HNE-d2 stand- 
& 0 
ard, and 200 ~1 of 0.05 M o-PFB,HCl in 0. I M PIPES buffer, pH 7.0. 
0 1 2 3 4 
The mixture was voruxcd for 1 min and allowed to stand at room Time (hours) 
temperature for 5 min. The mixture was then extracted 3 times by 
adding 1 ml of hcxane, vortcxing, centrifuging, and removing the 
upper organic layer. The hexanc extracts were combined, the solvent 
evaporated under a stream ofNI and 50~1 of MSTFA added. Samples 
were analyzed by CC/clcctron capture ionization mass spcctrometry 
using a VG Trio-2 CC/MS (VG Masslab, Altrincham, UK) instru- 
ment with a 15 m DE-5 capillary column (J&W Scientific, Folsom, 
CA) and splitless injection at an injector tcmpcraturc of 25O’C and 
He as carrier gas at a linear velocity of 35 cm/s. Oven temperature was 
programmed from 50°C to 250°C at lO”C/miu. Electron capture 
ionization (negative ion) was performed using methane as a buffer gas 
at a pressure of 5 x IO-’ mbar measured at the diffusion pump ma- 
nifold. The source temperature was held at 150°C. Selected ion mo- 
nitoring of /jr/: I52 and I54 was performed, corresponding to loss of 
the pentafhtorobenzyl and OTMS groups from the pentnfluorobrnzyl 
oximc derivatives of 4-HNE and its deuterated analoguc. Separation 
of syn and anti o.rime isomers was observed. A calibration curve was 
linear over 3 orders of magnitude (r? = 0.998). Concentration of MNE 
was calculated by measuring the 15Y154 peak area ratio and compar- 
ing to the calibration curve, and expressed as ng HNE/mI. Similar 
measurements were made for hcxanal and nonanal, again using deu- 
tcratcd standards. 
These were separated by HPLC and quantitated by post-column 
dcrivatization with chemilumincsccncc detection [Is-l 71. 
3. RESULTS 
3.1. Depletion o~antioxidtms itr &-exposed plasma 
Figure 1 shows a representative experiment revealing 
what happens to antioxidants when freshly-prepared 
human plasma is exposed to OS. Sixteen ppm of Oj was 
used to accelerate (for ease of measurement) the oxida- 
tive changes observed, since the surface/volume ratio in 
our experimental system is necessarily far lower than 
the enormous value found in the respiratory tract [29]. 
Similar results were obtained in 9 different experiments, 
utilizing plasma freshly obtained from 3 different 
donors at different imes. 
There was a rapid depletion of both uric acid and 
ascorbic acid: uric acid did not decline in the air-ex- 
posed controls and ascorbic acid remained constant (1 
experiment) or fell bjj S-i98 of its initial value (8 cx- 
periments) after 4 or 6 h incubation. Protein-SH groups 
declined more slowly in O,-exposed plasma, By con- 
trast, there was no significant change in a-tocopherol 
Fig. I. Depletion of antioxidants and protein thiol groups in human 
plasma cxposcd to I6 ppm O,, Results are cxpresscd as % of antiox- 
idant present (100% at zero time): some actual values arc shown in 
Table 1. Assays were performed as described in [I$181. Ascorbate 
results are corrected for the slow loss of ascorbate in an air-exposed 
control. The other antioxidants and protein thiols did not change in 
air-exposed controls, 
(the major inhibitor of lipid peroxidation in human 
plasma) or of bilirubin (not shown). Addition of 
catalase (lo3 enzyme units/ml) to the plasma before O3 
exposure to remove any H20z generated id not alter 
the results. 
The concentration of uric in human plasma is 5-10 
times greater than that of assorbic acid [20]. Since both 
of them disappear at approximately equal percentage 
rates when plasma is exposed to Oj, it follows that more 
of the O3 reacts with uric acid than with ascorbic acid 
(assuming that both molecules react with O:, on a l:! 
molar basis). Thus, exposure of 9 plasma samples to 16 
ppm O3 for 30 min led to a mean loss of 23 ,uM ascorbic 
acid (range 5-33 PM), but 89 PM uric acid (range 62- 
1 16 +M). After 1 h exposure, amean of 35 ,uM ascorbic 
acid (range 21-54 PM) was lost, but 170 ,uM (range 
106-225 PM) uric acid. After 1 h, a mean of 75 ,uM 
(range 37-128 PM) protein thiols had been lost. 
Oxidation of uric acid by reactive oxygen species ge- 
nerates several end-products, but the major one is 
usually allantoin [25]. This was also true for 03. Thus, 
in a representative plasma sample, 2 h exposure to 16 
ppm Oj oxidized 295 FM uric acid, and 80,uM allantoin 
was formed. Several other (unidentified) products were 
detected by HPLC [25]. O3 is reported to react with Hz0 
to form *OH [5]. However, oxidation of 400 PM uric 
acid in phosphate-buffered saline by 16 ppm O3 was not 
slowed by adding the aOH scavenger mannitol, tested up 
to 500 mM. Hence, even in buffer solution, .OH radicals 
appear not to contribute to the uric acid oxidation. 
They are even less like:jr to do so in plasma, which 
contains a vast range of compounds that scavenge -01-I 
[ 16,301. Hence O3 probably oxidizes uric acid and other 
plasma constituents directly. 
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The effects of adding extra ascorbic acid or uric acid 
to plasma, or of depleting plasma or uric acid by adding 
urate oxidase (1 unit/ml of Sigma uricase nzyme, added 
10 min before O9 exposure) were examined. HPLC con- 
firmed that the uric acid had been oxidized. Table I 
summarizes the results of several experiments. In gen- 
eral, the greater the amount of ascorbic acid or uric acid 
present, the faster the rate at which they were oxidized. 
Adding extra ascorbate did not slow the loss of uric 
acid, nor did depletion of uric acid (or adding extra) 
alter the loss of ascorbic acid (Table I). Similarly, ad- 
ding ascorbate or uric acid had only small effects on the 
loss of protein-SH groups (Table I). 
3.2. Attempts to measure lipid peroxidation 
Measurement of lipid hydroperoxides by a sensitive 
and specific assay [17-191 showed that only low con- 
centrations were formed (always cl ,uM, even after 6 h 
exposure to O3 in 6 experiments). Even these low levels 
were only measurable after prolonged (~2 h) exposure 
to 03. 
It could be argued that low levels of lipid hydro- 
peroxides are due to tbpir breakdown to other products, 
such as the cytotoxic aldehqde iqdroxynonenal [31], 
However, direct measurement of this aldehyde by dis- 
placement from protein, derivatization and GC-MS 
found none detectable in 6 different samples exposed to 
O3 for 2-6 h (limit of detection of the method used 0.0 I 
ng/ml). The preparation procedure used detects al- 
dehyde bound to protein amino groups, but not to -§I1 
groups. However, this is allowed for by calibrating the 
system with deuterated 4-hydroxynonenal dded di- 
rectly to plasma (70-758 recovery). Another possibility 
is that Oa fragments fatty acid side chains directly into 
aldehydes [32], such as hexanal and nonanal. However, 
analysis of the piasma samples for these two aldehydes 
failed to detect them. (Limit of detection 1 ng/ml.) 
Again, 70% detection of aldehyde standards added to 
plasma was achieved. 
Plasma lipoproteins are an important target for 
oxidative lipid damage [31,33]. However, no shifts in 
electrophoretic mobility of the different plasma lipo- 
protein species [33] were observed by agarose gel elec- 
trophoresis [19] after exposing plasma to OJ (tested up 
to 12 h) when compared with air-exposed controls. 
4. DISCUSSION 
Uric acid and ascorbic acid appear to be the major 
scavengers of O3 in plasma, but adding more of them 
causes them to be oxidized faster. How can this be 
explained? The reaction of Oj with body fluids is prob- 
ably an example of reactive absorptiott [34,351, i.e. the 
more oxidizable material present in the fluid, the more 
O3 is absorbed by the fluid to react with this material. 
When OJ is inhaled, the antioxidants in the upper 
RTLFs should combine with it, consuming OJ and pre- 
sumably protecting the underlying cells and the periph- 
eral, more sensitive bronchiolar-alveolar regions of the 
lung. Peden et al. [23] proposed that uric acid is the 
- 
Table I 
Oxidation of plasma constituents by ozone 
Parameters measurrd 
Experimental protocol Ascorbic acid (uM) Uric acid @M) Protein thiols (frM) 
-_ 
r=O r=lh % loss r=O r=lh 8 loss r=o r=lh 9 loss 
(I) Control exposure to 0, 
Uricase trealcd 
Supplemcnl~~ with 250 PM 
ascorbaie 
60 9 85 317 92 71 442 381 I4 
3:; 
9 87 48 0 I00 423 390 8 
44 86 373 88 76 430 367 I5 
(2) Control Exposure to 0, 
Supplemented with 1 mM 
uric acid 
Supplemented with I mM 
ascorbic acid 
84 64 445 329 26 
84 
: 
44 1445 409 72 - 
1084 440 59 445 233 52 - 
(3) Control exposure to 0, 59 23 61 396 I88 53 47B 400 16 
Supplemented with I.2 mM I214 346 II 409 149 64 - - 
ascorbic acid 
Supplemented with 1 mM 36 I4 61 1462 942 36 453 412 IO 
uric acid 
Supplemented with both I.2 mM 1258 780 62 I266 675 47 - - 
ascorbic and I mM uric acids 
Freshly-prepared human plasma from 3 different subjects was exposed to 16 ppm 0, for the times stated. Where indicated, ascorbic acid or uric 
acid wcrc added to give the fnal concentration stated. 
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antioxidant present in greatest concentration in human 
nasal secretions, and is secreted in greater amounts in 
response to irritants. Hatch [8] has shown that the 
human upper RTLFs contain little ascorbate or GSH, 
but considerable uric acid. We therefore propose that 
one physiological function of uric acid in upper RTLFs 
is to scavenge inhaled Oj. This may be important be- 
cause human upper RTLFs contain little ascorbate [8] 
and the content of albumin (and hence presumably of 
protein thiols) in RTLFs is much lower than in plasma 
11% 
It is frequently assumed that lipids are the major 
target of Oj-induced damage in vivo [1,2,6]. Our data 
suggest otherwise. Exposure of p!asma to 16 ppm OS, 
even for 6 h, produced little evidence of lipid damage, 
measured as aldehydes, lipid hydroperoxides or changes 
in lipoprotein electrophoretic mobility. Lipid peroxida- 
tion might be expected to produce losses of tz-toco- 
pherol and bilirubin, which were not observed. Oxidiz- 
ing agents can damage many other molecules, including 
proteins and DNA [36--381, and such damage is often 
more important han damage to lipids during oxidative 
stress. Indeed, we have recently found evidence for 
oxidative protein damage in Oj-exposed plasma [39]. 
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